Literature DB >> 25398256

The A395T mutation in ERG11 gene confers fluconazole resistance in Candida tropicalis causing candidemia.

Jingwen Tan1, Jinqing Zhang, Wei Chen, Yi Sun, Zhe Wan, Ruoyu Li, Wei Liu.   

Abstract

The mechanism of fluconazole resistance in Candida tropicalis is still unclear. Recently, we isolated a fluconazole-resistant strain of C. tropicalis from the blood specimen of a patient with candidemia in China. In vitro antifungal susceptibility of the isolate was determined by using CLSI M27-A3 and E-test methods. The sequence of ERG11 gene was then analyzed, and the three-dimensional model of Erg11p encoded by ERG11 gene was also investigated. The sequencing of ERG11 gene revealed the mutation of A395T in this fluconazole-resistant isolate of C. tropicalis, resulting in the Y132F substitution in Erg11p. Sequence alignment and three-dimensional model comparison of Erg11ps showed high similarity between fluconazole-susceptible isolates of C. tropicalis and Candida albicans. The comparison of the three-dimensional models of Erg11ps demonstrated that the position of the Y132F substitution in this isolate of C. tropicalis is identical to the isolate of C. albicans with fluconazole resistance resulting from Y132F substitution in Erg11p. Hence, we ascertain that the Y132F substitution of Erg11p caused by A395T mutation in ERG11 gene confers the fluconazole resistance in C. tropicalis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398256     DOI: 10.1007/s11046-014-9831-8

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  32 in total

Review 1.  Antifungal drug resistance of pathogenic fungi.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

Review 2.  Recent progress in the CYP51 research focusing on its unique evolutionary and functional characteristics as a diversozyme P450.

Authors:  Yuri Aoyama
Journal:  Front Biosci       Date:  2005-05-01

Review 3.  Sterol 14 alpha-demethylase and its inhibition: structural considerations on interaction of azole antifungal agents with lanosterol 14 alpha-demethylase (P-450(14DM)) of yeast.

Authors:  Y Yoshida; Y Aoyama
Journal:  Biochem Soc Trans       Date:  1991-08       Impact factor: 5.407

4.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

Authors:  J D Thompson; T J Gibson; F Plewniak; F Jeanmougin; D G Higgins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

Review 5.  Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

Authors:  T C White; K A Marr; R A Bowden
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

6.  Invasive candidiasis in intensive care units in China: in vitro antifungal susceptibility in the China-SCAN study.

Authors:  Wei Liu; Jingwen Tan; Jimei Sun; Zhijiang Xu; Min Li; Qing Yang; Haifeng Shao; Liyan Zhang; Weixia Liu; Zhe Wan; Wei Cui; Bin Zang; Dongpo Jiang; Qiang Fang; Bingyu Qin; Tiehe Qin; Weiqin Li; Fengmei Guo; Dawei Liu; Xiandong Guan; Kaijiang Yu; Haibo Qiu; Ruoyu Li
Journal:  J Antimicrob Chemother       Date:  2013-09-04       Impact factor: 5.790

7.  Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.

Authors:  M A Pfaller; A Espinel-Ingroff; E Canton; M Castanheira; M Cuenca-Estrella; D J Diekema; A Fothergill; J Fuller; M Ghannoum; R N Jones; S R Lockhart; E Martin-Mazuelos; M S C Melhem; L Ostrosky-Zeichner; P Pappas; T Pelaez; J Peman; J Rex; M W Szeszs
Journal:  J Clin Microbiol       Date:  2012-03-29       Impact factor: 5.948

8.  Fatal candidemia caused by azole-resistant Candida tropicalis in patients with hematological malignancies.

Authors:  Yong Chong; Shinji Shimoda; Hiroko Yakushiji; Yoshikiyo Ito; Toshihiro Miyamoto; Nobuyuki Shimono; Tomohiko Kamimura; Koichi Akashi
Journal:  J Infect Chemother       Date:  2012-04-18       Impact factor: 2.211

9.  Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes.

Authors:  J Versalovic; T Koeuth; J R Lupski
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

10.  Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.

Authors:  Nikolaos V Sipsas; Russell E Lewis; Jeffrey Tarrand; Ray Hachem; Kenneth V Rolston; Issam I Raad; Dimitrios P Kontoyiannis
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

View more
  11 in total

1.  General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation.

Authors:  Dora E Corzo-Leon; Mark Peacock; Patricia Rodriguez-Zulueta; Grace J Salazar-Tamayo; Donna M MacCallum
Journal:  Med Mycol       Date:  2021-07-06       Impact factor: 4.076

2.  Mechanisms of azole antifungal resistance in clinical isolates of Candida tropicalis.

Authors:  Saikat Paul; Dipika Shaw; Himanshu Joshi; Shreya Singh; Arunaloke Chakrabarti; Shivaprakash M Rudramurthy; Anup K Ghosh
Journal:  PLoS One       Date:  2022-07-12       Impact factor: 3.752

3.  Antifungal Susceptibility of Clinical Yeast Isolates from a Large Canadian Reference Laboratory and Application of Whole-Genome Sequence Analysis To Elucidate Mechanisms of Acquired Resistance.

Authors:  Lisa R McTaggart; Ana Cabrera; Kirby Cronin; Julianne V Kus
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

4.  Novel point mutations in the ERG11 gene in clinical isolates of azole resistant Candida species.

Authors:  Danielly Beraldo dos Santos Silva; Luana Mireli Carbonera Rodrigues; Adriana Araújo de Almeida; Kelly Mari Pires de Oliveira; Alexéia Barufatti Grisolia
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03-15       Impact factor: 2.743

Review 5.  Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.

Authors:  Sarah G Whaley; Elizabeth L Berkow; Jeffrey M Rybak; Andrew T Nishimoto; Katherine S Barker; P David Rogers
Journal:  Front Microbiol       Date:  2017-01-12       Impact factor: 5.640

Review 6.  Fluconazole resistance in Candida species: a current perspective.

Authors:  Elizabeth L Berkow; Shawn R Lockhart
Journal:  Infect Drug Resist       Date:  2017-07-31       Impact factor: 4.003

Review 7.  Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens.

Authors:  Ewa Ksiezopolska; Toni Gabaldón
Journal:  Genes (Basel)       Date:  2018-09-19       Impact factor: 4.096

8.  Rapid detection of ERG11 polymorphism associated azole resistance in Candida tropicalis.

Authors:  Saikat Paul; Rajneesh Dadwal; Shreya Singh; Dipika Shaw; Arunaloke Chakrabarti; Shivaprakash M Rudramurthy; Anup K Ghosh
Journal:  PLoS One       Date:  2021-01-13       Impact factor: 3.240

9.  Acquired multi-azole resistance in Candida tropicalis during persistent urinary tract infection in a dog.

Authors:  Sergio Álvarez-Pérez; Marta E García; María Teresa Cutuli; María Luisa Fermín; María Ángeles Daza; Teresa Peláez; José L Blanco
Journal:  Med Mycol Case Rep       Date:  2016-02-02

10.  MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.

Authors:  Longyang Jin; Zhuorui Cao; Qi Wang; Yichen Wang; Xiaojuan Wang; Hongbin Chen; Hui Wang
Journal:  BMC Infect Dis       Date:  2018-04-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.